Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Rotation Medical: Healing Rotator Cuff Tears

Executive Summary

Rotation Medical Inc.’s implantable collagen scaffold induces formation of new tendon-like tissue, and in some cases eliminates the need for suture anchors in surgical repair. This new technique has the potential to prevent rotator cuff disease progression and significantly reduce the incidence of re-tears.

You may also be interested in...



Smith & Nephew To Acquire Regenerative Shoulder-Tech Firm

Th UK firm is buying Rotation Medical and its regeneration technology for shoulder rotator cuff repair for $125m, plus milestones, to grow its sports-medicine portfolio. The deal comes amid rumors that Smith & Nephew could be positioning itself to be acquired.

Rotation's Bioinductive Shoulder Implant Succeeds In Australian Trial

The device has 510(k) clearance for a broad tendon-repair indication, but the company is sponsoring clinical trials to further validate the technology, which induces new tissue growth around partially torn rotator cuffs rather than simply mechanically reattaching it.

How Europe’s Nomenclature System Works And Offers New Insights

Transparency linked to new device registration rules will provide new market analysis possibilities. Medtech Insight delved deeper into the benefits of the European Medical Device Nomenclature with two Italian executives who see its potential.

Topics

Related Companies

Latest News
UsernamePublicRestriction

Register

MT035798

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel